Safety and Efficacy of Three Formulations of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution

Inclusion Criteria: * Ocular hypertension or primary open-angle glaucoma in each eye * Patient requires IOP lowering medication in each eye Exclusion Criteria: * Ocular hyperemia or other ocular surface findings in either eye * Active ocular disease * Current or anticipated use of any topical ocular medication (including artificial tears) during the study * Intraocular surgery within past six months or unilateral cataract surgery. * Functionally significant visual field loss * Anticipated wearing of contact lenses during study * Use of other medications that affect IOP such as glaucoma treating medications, within 2 months of screening visit